NCT06012370

Brief Summary

Injection of PRP and hyaluronic acid in stress incontinence patients

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
20

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2023

Completed
11 days until next milestone

First Posted

Study publicly available on registry

August 25, 2023

Completed
7 days until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2023

Completed
Last Updated

August 25, 2023

Status Verified

August 1, 2023

Enrollment Period

2 months

First QC Date

August 14, 2023

Last Update Submit

August 19, 2023

Conditions

Stress Incontinence, Female

Outcome Measures

Primary Outcomes (1)

  • Stress incontinence change

    Visual Assessment System assessment

    6 months

Study Arms (1)

Stress incontinence patients

OTHER

PRP injection

Procedure: PRP injection

Interventions

PRP injectionPROCEDURE

Injection of PRP and hyaluronic acid

Stress incontinence patients

Eligibility Criteria

Age20 Years - 60 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • stress incontinence patients

You may not qualify if:

  • prolapse patients

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Urinary Incontinence, Stress

Condition Hierarchy (Ancestors)

Urinary IncontinenceUrination DisordersUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesLower Urinary Tract SymptomsUrological ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant professor doctor

Study Record Dates

First Submitted

August 14, 2023

First Posted

August 25, 2023

Study Start

September 1, 2023

Primary Completion

October 31, 2023

Study Completion

October 31, 2023

Last Updated

August 25, 2023

Record last verified: 2023-08